Journal article · 2025

In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy

Dilan Ouyang, Rongjin Yang, Yuhang Yao, Fang Jiang, Sijie Song, Yuheng Yang, Edikan A. Ogunnaike, Zhitong Chen, Zhaowei Chen, Huanghao Yang

Journal of the American Chemical Society, 147(43), 39987–39998 · Published 15 October 2025 · DOI 10.1021/jacs.5c15945

View at the publisherCite this paper

In brief

“In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy” is a 2025 journal article by Dilan Ouyang and 9 co-authors, published in Journal of the American Chemical Society. OpenAlex counts 27 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
27
Most cited in
2026 (26)
Field-weighted impact
5.36
References
62
Authors
10

Abstract

Proteolysis-targeting chimeras (PROTACs) have transformed therapeutic interventions by hijacking the ubiquitin-proteasome system. However, their broad application is hindered by inadequate cellular permeability and undesired off-tissue effects. Here, we introduce a modular strategy for the in situ synthesis of PROTACs through pathologically activated bioorthogonal catalysis (ABC-PROTAC), enabling targeted protein degradation specifically in cancer cells. This platform… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ouyang, D., Yang, R., Yao, Y., Jiang, F., Song, S., Yang, Y., Ogunnaike, E. A., Chen, Z., Chen, Z., & Yang, H. (2025). In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy. Journal of the American Chemical Society, 147(43), 39987–39998. https://doi.org/10.1021/jacs.5c15945

MLA 9

Ouyang, Dilan, et al. “In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy.” Journal of the American Chemical Society, vol. 147, no. 43, 2025, pp. 39987–39998. https://doi.org/10.1021/jacs.5c15945.

Chicago

Ouyang, Dilan, Rongjin Yang, Yuhang Yao, Fang Jiang, Sijie Song, Yuheng Yang, Edikan A. Ogunnaike, Zhitong Chen, Zhaowei Chen, and Huanghao Yang. 2025. “In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy.” Journal of the American Chemical Society 147 (43): 39987–39998. https://doi.org/10.1021/jacs.5c15945.

Harvard

Ouyang, D. et al. (2025) ‘In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy’, Journal of the American Chemical Society, 147(43), pp. 39987–39998. doi:10.1021/jacs.5c15945.

IEEE

D. Ouyang et al., “In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy,” Journal of the American Chemical Society, vol. 147, no. 43, pp. 39987–39998, 2025, doi: 10.1021/jacs.5c15945.

BibTeX

@article{ouyang2025situ,
  title     = {{In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy}},
  author    = {Ouyang, Dilan and Yang, Rongjin and Yao, Yuhang and Jiang, Fang and Song, Sijie and Yang, Yuheng and Ogunnaike, Edikan A. and Chen, Zhitong and Chen, Zhaowei and Yang, Huanghao},
  journal   = {Journal of the American Chemical Society},
  year      = {2025},
  volume    = {147},
  number    = {43},
  pages     = {39987--39998},
  doi       = {10.1021/jacs.5c15945},
  url       = {https://doi.org/10.1021/jacs.5c15945}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • bioorthogonal catalysis
  • targeted protein degradation
  • AS1411 aptamer
  • liposomal drug delivery
  • nucleolin
  • tumor targeting
  • BRD4 degradation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Ouyang, D., Yang, R., Yao, Y., Jiang, F., Song, S., Yang, Y., Ogunnaike, E. A., Chen, Z., Chen, Z., & Yang, H. (2025). In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy. Journal of the American Chemical Society, 147(43), 39987–39998. https://doi.org/10.1021/jacs.5c15945

How many times has this paper been cited?

27 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Dilan Ouyang, Rongjin Yang, Yuhang Yao, Fang Jiang, Sijie Song, Yuheng Yang, Edikan A. Ogunnaike, Zhitong Chen, Zhaowei Chen, Huanghao Yang.

What is the DOI of this paper?

10.1021/jacs.5c15945, permanently at https://doi.org/10.1021/jacs.5c15945. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.